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Abstract
 .Acid a-glucosidase GAA hydrolyzes a-1, 4 and a-1, 6 glucosidic linkages of oligosaccharides and degrades glycogen
in the lysosomes. The full-length GAA I cDNA, pQAM8, was isolated from a cDNA library derived from Japanese quail
liver. The cDNA is 3569 base pairs long and has an open reading frame capable of coding 932 amino acids. The deduced
amino acid sequence shares 52% identity with human GAA. Transfection of expression vector pETAM8 into COS-7 cells or
 .acid maltase deficient AMD quail embryonic fibroblasts increased the level of GAA 20–50-fold. Compared to normal
quail, the levels of GAA I mRNA were significantly reduced in the muscle, liver, heart, and brain of AMD quails,
suggesting the GAA deficiency in AMD quail is due to a lack of GAA I mRNA. A second GAA II cDNA was identified
after probing the cDNA library from the ovarian large follicles of quails with a PCR product derived from cultured quail
 .skin fibroblasts. This clone having 3.1 kb insert, has GAA activity as well 3 to 10 fold increase . This cDNA, designated
GAA II, predicted an 873 amino acid polypeptide showing 63% identity to human GAA and 51% identity to the GAA I.
The RT–PCR analysis demonstrated that GAA II mRNAs were barely detectable in normal tissues, while they were
enhanced to higher levels in AMD tissues. These results suggest that GAA II expression is up-regulated at the transcription
levels, and quail GAA gene redundancy performs the same function of satisfying GAA demand at the two different phases
represented by normal and AMD. q 1998 Elsevier Science B.V.
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1. Introduction
 .Acid a-glucosidase GAA , also called acid mal-
tase, is a lysosomal enzyme that hydrolyzes a-1, 4
and a-1, 6 glucosidic linkages of oligosaccharides
and degrades glycogen in the lysosomes. The gene
for human acid a-glucosidase is located on chromo-
some 17q23 and is designated as GAA human acid
. w xa-glucosidase on the human gene map 1 .
A genetic deficiency of lysosomal GAA is inher-
w xited as an autosomal recessive trait 2,3 and is called
 .acid maltase deficiency AMD or Pompe disease,
also known as glycogenosis type II disease. AMD is
clinically and genetically heterogeneous and can be
w xpresent as an infant, as a juvenile, or as an adult 3,4 .
The infantile form is characterized by hypotonia and
severe accumulation of glycogen in the heart and
skeletal muscles, liver, and other tissues. In the adult
or late-onset form, the symptoms are usually limited
to skeletal muscle weakness. Respiratory and heart
failure are the main causes of death. Because the
human cDNA sequence and structural gene are
known, clinical manifestations of AMD can be corre-
w xlated with the molecular defects 5–9 .
Recently, significant advances have been made to
develop an enzyme replacement therapy for AMD.
To adequately study the mechanisms, biological func-
tion, and efficacy of such a proposed therapy, an
appropriate animal model is needed. The only re-
w xported animals with AMD are Short-horn cattle 10 ,
w x w xBrahman cattle 11 , and Japanese quail 12–15 .
 .A Japanese quail with AMD AMD quail was
w xfirst described 17 years ago in Japan 12 . A breeding
stock was established and the affected birds have
been evaluated for their suitability as an animal model
w xof human AMD 12,14,15 . The genetics, clinical
course, histochemistry in muscle, and biochemical
data closely resemble the human late-onset form
w x14,15 . The disease is inherited as an autosomal
recessive trait. The main clinical symptom of AMD
quail is progressive muscle weakness, and the activity
of GAA in pectoralis muscles is reduced to approxi-
mately 16% of the normal level from embryonic
w xstages to adulthood 15 . The present study reports
the molecular cloning of a full length quail GAA I
mRNA and demonstrates that the reduction of GAA
activity in AMD quail is due to a lack of GAA I
mRNA. We also found a second GAA II cDNA
which might be responsible for the residual activity
retarding the progression of disease in AMD quails.
2. Materials and methods
2.1. Normal and AMD quail
Japanese quail with acid a-glucosidase deficiency
 .  .  .AMD strain RWN and normal birds strain PNN
were obtained from the Nippon Institute for Biologi-
cal Science Farm, Kobuchizawa, Yamanashi, Japan.
Sex identification and clinical assessment for wing
dysfunction were performed at 3 weeks after hatch-
ing. The animals were cared for in compliance with
the law and related standards for the animal welfare.
2.2. cDNA cloning and sequencing of GAA I and
GAA II cDNA
2.2.1. GAA I cDNA
A cDNA library was generated from RNA isolated
from the liver of a 40 day old normal male quail and
 .cloned into the lZAP II vector Stratagene as de-
w xscribed by Gubler and Hoffman 16 . Two conserved
  .regions of G A A FH Lr Q C R W G Y and
 . .MNE PrF SNFI were chosen based on comparisons
w xof the amino acid sequences from human 7 , mouse,
w xand tetrahymena 17 in the DDBJrEMBLrGenBank
database. Degenerate oligonucleotides to these two
 X Xregions 5 -TTCCAYCTGTGCCGNTGGGNTA-3
X X.and 5 -ATRAARTTRGAAGGYTCRTTCAT-3 were
synthesized. These oligonucleotides were used as
primers in a reverse transcriptase primed polymerase
 .chain reaction RT–PCR from liver RNA in a 40
day old male quail. The PCR product with approxi-
mately 470 bp length was used to probe a liver
cDNA library, and a cDNA clone, pQAM8, contain-
ing a 3.6 kb insert was isolated. Both strands of the
pQAM8 were sequenced with the thermo sequence
 .kit Amersham on an automated DNA sequencer
 .ABI 373A .
2.2.2. GAA II cDNA
The second GAA cDNA fragment was cloned
from total RNA prepared from cultured skin fibrob-
lasts from 9-day quail embryos using TRIZol reagent
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 .Life Technologies . The RT–PCR was performed
with random hexamer as primer. The reverse tran-
scriptase cDNA mixture was then subjected to 30
amplification cycles with the following primers. Sense
primer used in the amplification reaction was
 .  XGA794 q 5 -GATCCAGCTAACAGGCGCTACG
.AGGTGCCC and anti-sense primer used was
 . X .GA1782 - 5 -CTCGTTCATGTCAATCCA . One
 .PCR fragment about 1 kb in size was amplified.
The PCR product was used to probe a cDNA library
w xfrom ovarian large follicles of female quails 18 , and
a cDNA clone, pQRKT6, which contained a 3.1 kb
insert was isolated. Both strands of the pQRKT6
 .were sequenced with the same way noted above .
2.3. Transient expression and enzyme assay
The GAA I expression plasmid, pETAM8 was
constructed by cleaving pQAM8 with HincII and
XbaI which cleave the 5X non-coding region and
vector, respectively, and then by subcloning the insert
 .into the expression vector pcDNA3 Invitrogen , di-
gested with EcoRV and XbaI. The GAA II expres-
sion plasmid, pETRKT6 was constructed by cleaving
pQRKT6 with EcoRI and subcloning the insert into
the EcoRI sites of pcDNA3. Large-scale preparations
of the expression-type plasmids were made using the
CsCl–ethidium bromide ultracentrifugation method
w x  .19 . LipofectAMINE reagent Gibco BRL was used
to transfect these plasmids into primary fibroblasts
from the skins of 9-day embryonic AMD quails or
COS-7 cells. Ninety hours post-transfection, the cells
were dissolved in water and cell extracts were pre-
pared by three freeze and thaw cycles. The GAA
activity in cell extracts was measured photometrically
using the substrate 4-methyl-umbelliferyl-a-D-gluco-
 .pyranoside 4-MU in citrate–phosphate buffer for
w x 1 h at 378C 20 . A Bradford protein assay kit Bio-
.Rad was used to measure protein concentrations.
2.4. RNA isolation and Northern blot analysis
 .Total RNA from pectoralis breast and adductor
 .leg muscles, liver, heart, and brain of male normal
and AMD quails was prepared by the guanidine
w xthiocyanaterCsCl method 19 . For the Northern
blotting, 15 mg of total RNA was loaded per lane on
an 0.7 M formaldehyde agarose gel. After elec-
trophoresis, the RNA was transferred onto a Hybond
 .Nq nylon membrane Amersham by a capillary
action with 10= SSC. The nylon membrane was
hybridized with a 32P-labeled GAA cDNA probe in
 .0.5 M sodium phosphate buffer pH 7.2 containing
7.5% SDS and 1 mM EDTA for 16 h at 658C. The
membrane was washed in 2= SSC, 0.1% SDS at
 .658C and exposed XAR film Kodak or BMS film
 .Kodak for 2 days at y808C. The GAA probe was
removed and the membrane was rehybridized with a
w xchicken GAPDH cDNA probe 21 .
2.5. RT–PCR of GAA I and II mRNAs in normal and
AMD quails
The RNA was isolated from livers, hearts and
pectoralis muscles of three male normal and three
male AMD quails at 30 days after hatching. A total
of 1 mg RNA was subjected to the reverse transcrip-
tase reaction in a 40 ml mixture containing 50 mM
 .Tris–HCl pH 8.3 ; 75 mM KCl, 3 mM MgCl ; 1002
 .mM DTT; 15 units RNase inhibitor TOYOBO ; 100
nM each dATP, dGTP, dTTP, dCTP; 200 ng random
 .hexamer Pharmacia Biotech, Uppsala ; and 200 units
M-MLV reverse transcriptase BRL, Gaithersburg,
.MD at 428C for 1 h. Ten pg cDNA synthesized in
one reaction was amplified by PCR applying 22, 24,
26 and 28 cycles. The reaction cycle-PCR product
yield curves of each reaction mixture were plotted on
semi-logarithmic graphs. The regression equation y
s I=En, where y is the yield and n is the number
of cycles, was fitted to the data in the linear portion
w xof the curves 22 to estimate the initial amount of
GAA I and II mRNA levels. The PCR reaction
mixtures contained either 0.5 mM GAA I primer and
0.1 mM GAPDH primer, or 0.5 mM GAA II primer
and 0.1 mM GAPDH primer. One cycle consisted of
958C, 30 s for denaturation, 608C, 120 s for anneal-
ing, and 728C, 120 s for elongation. The primers used
were 5X-TGATCCCCAGAAATTTGCCTCCC-3X
 . Xforward and 5 -ACCGTCTTGGCAGTCAGG-
X  . XGAATT-3 reverse for GAA I, 5 -TACCCTGA-
X  . XCATGGTGCACGACTT-3 forward and 5 -
X  .TGTCACCAGCAAAGCCACAGATG-3 reverse
for G A A II, and 5 X-G G A G C A G G T A -
X  . XCACTATAAGG-3 forward and 5 -TC -
X  .CAACAAAGGGTCCTGCTT-3 reverse for
w xGAPDH 23 . The PCR products were elec-
trophoresed on 1.5% agarose gel. The density of each
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band stained with ethidium bromide, was measured
 .by Densitograph ATTO, Tokyo . The relative
amounts of mRNA levels among tissues, phenotypes
and two genes were indicated as average percentages
to the 100% level in GAA I mRNA of normal liver.
3. Results
3.1. Cloning and sequencing of GAA I and II cDNAs
in Japanese quail
Degenerate oligonucleotides from conserved re-
gions of the GAA protein were used as primers to
amplify a region of the GAA from quail liver mRNA.
 .We used this PCR product as a probe Fig. 1 and
identified more than 40 positive clones from 4=105
phage plaques of a cDNA library derived from RNA
from the liver of a normal 40 day old Japanese quail.
We used an in vivo excision method Stratagene
.protocol to isolate 10 of the 40 positive clones. Of
the 10 clones, pQAM8 contained the longest insert
 .3569 nucleotides long , and both strands were se-
 .quenced Fig. 1 . The longest open reading frame
was 932 amino acid residues, which started at posi-
tion 544 and ended with a stop codon at position
3342. Because the sequence around the first ATG
 .Fig. 1. Nucleotide and deduced amino acid sequences from Japanese quail acid a-glucosidase GAA I cDNA, pQAM8. The regions for
 .degenerate primers used in RT–PCR reactions are underlined by arrows. The upstream in-frame stop codon TGA and polyadenylation
 .  .signal AATAAA are underlined. The downstream in-frame stop codon TGA is indicated by an asterisk. Nine possible glycosylation
sites are surrounded by circles. This cDNA sequence has been deposited with DDBJrEMBLrGenBank DNA database under the
accession number of AB000967.
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 .Fig. 2. The nucleotide and deduced amino acid sequences from second acid a-glucosidase GAA II cDNA which was identified after
probing cDNA library from quail ovarian large follicles with a PCR product derived from cultured quail skin fibroblasts. The two
conserved regions chosen as primers are underlined. The longest open reading frame was 873 amino acid residues, which started at
position 7 and ended with a stop codon at position 2628. The deduced amino acid sequence in GAA II cDNA, had four possible
 .glycosylation sites Asn-X-SerrThr . This cDNA sequence has been deposited with DDBJrEMBLrGenBank DNA database under the
accession number of AB006754.
w xcodon matched the Kozak’s consensus sequence 24
and there was an upstream in-frame stop codon, we
assumed that this insert contained the complete cod-
ing sequence. This insert had a relatively large 5X
 .non-coding region approximately 550 bp and a
 .polyadenylation signal AATAAA at position 3532,
followed by stretch of adenosine residues starting at
 .position 3548 Fig. 1 .
This authentic cDNA was named GAA I cDNA,
because mRNA expression was approximately 10-fold
 .higher than that of GAA II cDNA see below . The
deduced amino acid sequence in GAA I cDNA had
 .nine possible glycosylation sites Asn-X-SerrThr
 .Fig. 1 and shared 52% identity with mouse and
human GAA sequences. We found that of the 13
amino acids around the putative catalytic sites, 12
 .  .Fig. 3. The sequence alignment of amino acid sequences from human acid a-glucosidase GAA cDNA accession number of Y00839 ,
Japanese quail GAA I and GAA II. Residues identical among the three species are marked with asterisks. The putative catalytic sites are
indicated by black reverse shading. The quail GAA I and GAA II shared only 51% identity in amino acid sequences. The quail GAA I
shared 52% and 51% identity in amino acid sequences with human GAA and GAA II, respectively, while quail GAA II shared higher,
63% identity with human GAA. We found that of the 13 amino acids around the putative catalytic sites in GAA II protein, 12 were
conserved in quail GAA I, and 13 in humans.
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w xwere conserved in humans 25 , 11 in mouse, and 10
w xin tetrahymena 17 . The quail GAA I is about 20-
amino acids shorter than mammalian GAA. The
length difference is due primarily to a gap in the
C-terminal region of the quail GAA I. The N-termi-
nal regions are poorly conserved among the three
( )R. Kunita et al.rBiochimica et Biophysica Acta 1362 1998 269–278 275
species. The lack of conservation of N-termini is
consistent with the proteolytic processing of this re-
w xgion known to occur in the human GAA protein 6 .
A second GAA II cDNA was identified after
probing a cDNA library from ovarian large follicles
of quails with a PCR product derived from cultured
quail skin fibroblasts. This cDNA was 3112 bp in
size and its deduced amino acid sequence shares 63%
identity with mouse and human GAAs. The longest
open reading frame was 873 amino acid residues,
which started at position 7 and ended with a stop
codon at position 2628. Because the sequence around
the first ATG codon matched the Kozak’s consensus
w xsequence 24 and was capable of expressing catalytic
GAA activity, we assumed that this insert contained
coding sequence for functional enzyme protein. The
deduced amino acid sequence in GAA II cDNA, had
 .four possible glycosylation sites Asn-X-SerrThr
 .Fig. 2 . We found that, of the 13 amino acids around
the putative catalytic sites in GAA II protein, 12 were
w xconserved in quail GAA I, and 13 in humans 25
 .Fig. 3 .
3.2. Transient expression of GAA cDNA in embryonic
fibroblasts or COS-7 cells
The coding sequence of pQAM8 and pQRKT6
was subcloned into pcDNA3 to construct the expres-
sion plasmids, pETAM8 and pETRKT6 for GAA I
and GAA II, respectively. We transfected those plas-
mids into primary fibroblasts derived from 9-day
AMD embryos or COS-7 cells. To be sure that GAA
activity assayed was indeed acid, and not neutral, we
measured GAA activity at both acid pH, 4.3, and
neutral pH, 6.5. As we expected based on the pH
optimum of mammalian GAA, at neutral pH GAA
activity was less than 5% of the GAA activity mea-
sured under acidic conditions. In each of three experi-
ments, the transfections with the pETAM8 into the
embryonic fibroblasts or COS-7 cells resulted in a
20- to 50-fold increase of GAA activity. In a typical
transfection, the activity was 210 nmol 4-MUrmg
proteinrh, while GAA activity from mock transfec-
tion with pcDNA3 vector was only 7.26 nmol 4-
MUrmg proteinrh. The GAA activities tended to be
higher in the transfected embryonic fibroblasts than
in COS-7 cells. The GAA II activity in COS-7 cells
transfected with pETRKT6 also raised to 3–10 times
higher than those transfected with pcDNA3 vector.
These results strongly suggest that both 3.6 kb GAA I
cDNA and 3.1 kb GAA II cDNA contained a se-
quence encoding functional GAA protein in Japanese
quail.
3.3. Northern blot and RT–PCR analysis of GAA I
and II mRNA in normal and AMD quails
In Northern blots probed with 32P-labeled quail
GAA I cDNA, a single 3.6 kb band was detected in
 .total RNA 15 mgrlane from normal quail pectoralis
 .Fig. 4. The Northern blot analysis of total RNA 15 mgrlane
 . from normal odd-numbered lanes and AMD quail even-num-
. 32bered lanes probed with the P-labeled insert of pETAM8: liver
 .  . 1 day old , lanes 1, 2; liver 84 day old , lanes 3, 4; heart 35
.  .day old lanes 5, 6; pectral muscle 35 day old lanes 7, 8;
 .  .adductor muscle 84 day old , lanes 9, 10; and brain 35 day old ,
lanes 11, 12. The same membrane was rehybridized with a
chicken GAPDH coding sequence.
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 .  .Fig. 5. The quantitative RT–PCR analysis to determine GAA I GI; 423 bp and GAA II GII; 423 bp mRNA levels in liver, heart and
 .pectoralis muscle of normal Nor and AMD quails at 30 days after hatching. The quail GAPDH coding sequence with 1084 bp was used
as an internal control. The PCR products amplified in 28 cycles were stained with ethidium bromide. The relative amounts of PCR
products were compared among tissues, phenotypes, and two genes on the 100% of the liver GAA I mRNA. Note that no GAA I mRNA
 .was detected in any AMD tissues ND while the GAA II mRNA expression was strongly enhanced in the heart and pectoralis muscle of
AMD quails.
muscle, adductor muscle, heart, brain and liver. We
detected no or very low mRNA signals with this
probe in every tissue examined in AMD quails Fig.
.4 . Reprobing the membrane with chicken GAPDH
probes revealed the presence of RNA in all lanes.
Thus, GAA I mRNA expression is significantly re-
duced in AMD quails.
The RT–PCR analysis demonstrated that GAA II
mRNA was barely detected in tissues of normal
quail, and that no GAA I mRNA was detected in
AMD tissues whereas GAA II mRNA in heart and
pectoralis muscle in AMD quails showed 2.3 and
3.8-fold increase in transcript level, respectively,
compared to heart and pectoralis muscle in normal
 .quails Fig. 5 .
4. Discussion
In the course of GAA cDNA cloning, we isolated
a second GAA II cDNA clone which was 165 bp
nucleotide shorter in the N-terminal region than the
first GAA I cDNA. Because the sequence around the
first ATG codon matched the Kozak’s consensus
w xsequence 24 and the transfection of GAA II cDNA
into COS-7 cells showed a 10 fold increase of pH 4.3
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GAA activity over mock transfected cells, we as-
sumed that this insert contained a sequence encoding
functional GAA protein. The deduced amino acid
sequence from GAA II cDNA shares 63% identity
with mammalian GAAs but only 51% identity with
the authentic GAA I in quails. This result may ex-
plain why the cDNA probe of the first GAA I gene
did not recognize the messenger of the second GAA
II gene.
To date, only one GAA gene has been detected in
w xmammals 5–8 , whereas two GAA genes were found
in quail genomes, leading to the speculation that a
common ancestor shared by mammals and birds had
two GAA genes, and the GAA I gene in quails may
have led to the rapid divergence in species-specific
function during evolution. By contrast, the GAA II
gene in birds is less important for birds-specific
function than the authentic GAA I gene. Whether
mammals have only one GAA gene or still hide other
redundant genes behind an authentic GAA gene need
to be studied. There are a number of examples
demonstrating that experimental inactivation of cer-
tain genes has no effect on the phenotype of an
animal. Such genetic redundancy means that two or
more genes are performing the same function and
that inactivation of one of these genes has little or no
w xeffect on the biological phenotype 26–30 .
Northern blot and RT–PCR analyses demonstrated
that no GAA I mRNA was expressed in tissues of
AMD quails, and the transcript levels of GAA II
mRNA in AMD heart and pectoralis muscle in-
creased about 2–3-fold higher than those in normal
tissues. The low GAA II mRNA signals in AMD
liver may account for earlier and much more accumu-
lation of intracellular glycogen granules than in other
w xtissues 14 . A similar lack of GAA mRNA has been
reported in some AMD patients and in AMD Brah-
w xman cattle 5,7,11,31,32 . The affected cattle has a
severe early onset phenotype. Almost all patients who
lacked GAA mRNA were affected with the infantile
form of AMD. However, even though the AMD quail
lacked detectable GAA I mRNA, their clinical pheno-
types were not as severe as the infantile AMD pa-
tients and more closely resembled the late-onset form
w xof AMD 14,15 . Although the in vivo function of the
second GAA II is not clear, this additional enzyme in
AMD quail may account for the residual GAA activ-
ity and slow progression of the disease in spite of a
severe reduction of authentic GAA I mRNA. This
speculation was further strengthened by the transfec-
tion assay using SV40 transformed Pompe fibrob-
lasts, demonstrating that, in addition to GAA I, GAA
II also can hydrolyse the natural glycogen and mal-
 .tose data not shown . The GAA II cDNA was cloned
from cultured quail fibroblasts and its transcript level
in AMD tissues rose to higher levels than in normal
tissues. These results suggest that the accumulation of
GAA II mRNA in AMD tissues might be due to the
increase in number of regenerating cells andror to
the rise of transcript level in all cells in AMD tissues.
w xBiochemically, Suhara et al. 33 suggested that a
110 kDa aberrant precursor form of GAA might not
be processed to the 98 kDa mature GAA in AMD
quail. Our results, however, do not support their
speculations but indicate that the defect is in the level
of mRNA in the tissue. We suggest that it is possible
that in those Western blot analysis, the antiserum
recognized also a second GAA II protein. In other
words, the whole chicken GAA protein isolated was
likely to contain two different types of GAA proteins,
leading to recognition of two GAA proteins by the
polyclonal antibody.
We showed here that an undetectable level of
authentic GAA I mRNA leads to severe reduction of
GAA protein in AMD quails. If the quails do not
have such second GAA II gene, the type of AMD in
quails must be an infantile-form, leading to the death
in early stages of the development. Based on the
results in this report, the AMD quails could be an
ideal animal model for the molecular studies on the
pathogenesis of human Pompe disease, the enzyme
w xreplacement therapy with recombinant GAA 34 , and
the gene therapy using a recombinant adenoviral
w xvector 35 .
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